Home / Business and Economy / India's Valuation Trap: Exits Freeze Amidst Boom Bust
India's Valuation Trap: Exits Freeze Amidst Boom Bust
19 Mar
Summary
- Aggressive 2021-22 pricing left Indian firms overvalued.
- Secondary deals now see 40-50% discounts, up from 20-30%.
- IPOs are struggling to validate previously high private valuations.
India's private capital ecosystem faces a significant valuation challenge following the 2021-22 venture capital boom. Many companies are now overvalued relative to their fundamentals, making it difficult to exit investments as the market turns cautious. Strategic sales have yielded disappointing results, and secondary market transactions are now experiencing discounts of 40-50%, a sharp increase from the previous 20-30% norm.
The core issue lies in a valuation mismatch, where early and growth-stage rounds were often priced at 10-20x ARR multiples. Current public market valuations for comparable companies are significantly lower, typically 5-7x revenue multiples. This divergence widens the gap between buyer and seller expectations, impacting late-stage transactions and IPO exits. Companies like PhonePe, Meesho, CRED, and PharmEasy have already seen substantial valuation resets in recent deals.
Despite these hurdles, Initial Public Offerings (IPOs) remain a primary exit channel, with 19 pure offers-for-sale since January 2025. However, public markets are increasingly reluctant to absorb inflated private valuations without correction. As of March 11, 2026, 82 out of 115 listed companies were trading below their listing-day close, with average listing gains in Q1 2026 drastically reduced. Investors are pushing for liquidity, sometimes through IPOs even when founders prefer strategic sales, while regulators warn about the risks of opaque private valuations distorting public market discovery.
